Does vaginal delivery of combined hormonal contraception affect the risk of metabolic syndrome in overweight/obese women with PCOS?

Brief description of study

This research study is being conducted to determine if there is an effect on the development of Metabolic Syndrome (MetS) in women with PCOS when using NuvaRing. This study will recruit 40 women between the ages of 18-40, with a diagnosis of PCOS, NO diagnosis of MetS, and a BMI between 25 and 45. Women will be asked to use NuvaRing for 4 months. They will have fasting bloodwork (including OGTT) at baseline and four months, and will be contacted once a month by research staff.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Polycystic Ovary Syndrome, PCOS
Age: - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 834422

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).